updated results of griffin: d-rvd vs rvd in patients with newly diagnosed multiple myeloma
Published 2 years ago • 303 plays • Length 3:51Download video MP4
Download video MP3
Similar videos
-
2:13
griffin updates: d-rvd vs rvd in transplant-eligible patients with newly diagnosed multiple myeloma
-
1:17
an update on griffin: d-rvd in patients with newly diagnosed multiple myeloma
-
2:07
post hoc analysis of griffin: d-rvd vs rvd in ndmm
-
3:05
updates from the determination trial: rvd vs. autosct in patients with multiple myeloma
-
7:22
griffin update: depth of response to d-rvd in transplant eligible ndmm
-
7:31
clinical trial: darzalex (daratumamab) with revlimid/velcade/dex for newly diagnosed myeloma
-
3:04
is a generic version of revlimid available?
-
2:49
what does the approval of darzalex faspro™ mean for myeloma patients?
-
2:12
griffin: follow-up after dara rvd for multiple myeloma
-
1:52
myeloma: follow-up of griffin study
-
1:34
griffin: subgroup analysis of patients with multiple myeloma with high-risk cytogenetics
-
2:33
an update on antibody-based treatment approaches in multiple myeloma
-
1:22
long-term follow-up results of tourmaline-mm2: ird vs pbo-rd in multiple myeloma
-
3:45
update on phase i trial of teclistamab in r/r myeloma
-
1:23
dr. braunstein on updated results of the griffin trial in multiple myeloma
-
1:00
the recent fda approval of teclistamab for r/r multiple myeloma
-
2:09
the candor trial extended follow-up: daratumumab for r/r myeloma
-
3:51
daratumumab in multiple myeloma: an overview of 3 key trials
-
1:54
castor trial update: daratumumab/bortezomib/dexamethasone is an important regimen for r/r mm
-
2:52
update on iberdomide treatment combinations in r/r myeloma
-
2:07
manhattan: carfilzomib, lenalidomide, dexamethasone, and daratumumab for newly diagnosed myeloma
-
4:45
a first-in-human trial of regn5458 in r/r myeloma: updated phase i data